Home/SEC 13D/G/DFTXSEC 13D/GDFTX - Definium Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$DFTX$44.18▲ 223.66% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #DFTX Definium Therapeutics, Inc. : $44.18 Sector: Healthcare | YTD: 🔼+ 223.66% The SEC disclosed Today (14-AUG-2026) that DRIEHAUS CAPITAL MANAGEMENT LLC has INCREASED #DFTX Shares by 15.79% 🟢 * Previous Holdings: 5.91M Shares * Current Holdings: 6.85M Shares * Increase+933.39K * Increased(%)+15.79% * Ownership: 5.36% * Estimated Investment Value: $40.76M https://www.thinksabio.com/reports/isr/DFTX Institutional ownership in #DFTX has been steadily rising over the past 3 quarters in Shares: Q3 2025: 39.74M Q4 2025: 67.86M Q1 2026: 78.05M The quarterly average prices of #DFTX: Q3 2025: $9.33 Q4 2025: $12.36 Q1 2026: $16.97 Share this post🔗Copy Link💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G